Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2015 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (257)	2/20/2015 8:09:04 PM
From: mopgcw	Read Replies (1) \| Respond to of 407

YES! achieved my goal. made the top 10 again this year for a brief moment. it's the little things really. thanks Bulba.

To: BulbaMan who wrote (257)	2/27/2015 8:05:30 PM
From: BulbaMan	Read Replies (1) \| Respond to of 407

2/27/15 Contest update With Dr. Spock gone, the Department of Homeland Security unfunded and the Contest median at an acrophobia-inducing 2015 high, not to mention the approaching Ides of March, for some it may be a nervous weekend. At Friday’s close, the Contest median was up 16.92% YTD (vs. up 14.60% YTD a week ago), while there were smaller weekly gains for both the Nasdaq Biotech Index, up 11.08% YTD (vs. up 10.66% YTD a week ago) and the Nasdaq Composite Index, up 4.80% YTD (vs. up 4.64% YTD a week ago). Starting this week I began to track the smaller-cap S&P Biotechnology Select Industry Index (Yahoo symbol is ^SPSIBI), which closed Friday up 15.00% YTD. With its European biotechs continuing to gain ground, OLIVIER’s portfolio, up 48.24% YTD, remained Contest leader. A boost from ARQL helped MCBIO’s portfolio, up 45.72% YTD, move into second place and GENE’s portfolio, up 44.32% YTD, slipped to third place. At Friday's close, a whopping 49 of the 51 Contest portfolios were in the black with 33 beating the NBI and 29 beating the SPSIBI. The 206 Contest stock picks have an average YTD gain of 14.54% Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: NPSP buyout by Shire for $46. NPSP was only in ROBO’s portfolio and I used the 2/27/15 closing prices for the reallocation. (All corrections, especially adjustments for splits, greatly appreciated.) Have a relaxing weekend biotechies! Peace & good health, Bulba 2/27/15 Rank Name Profit/Loss 1 OLIVIER 48,244 2 MCBIO 45,716 3 GENE 44,321 4 OHMS 43,252 5 DONS 36,143 6 GADGET 34,078 7 BLADE 33,384 8 IMAN 32,549 9 ARTHUR 30,884 10 THEOX 29,594 Week's Top 5 Gainers Symbol 2/20/15 2/27/15 Wk.%chg. EYES 8.750 16.170 84.80% EDT.TO 0.405 0.620 53.09% ARQL 1.350 1.880 39.26% ALCLS.PA24.320 30.780 26.56% SUMM.L 147.500 183.000 24.07% Week's Worst 5 Losers Symbol 2/20/15 2/27/15 Wk.%chg. SPPI 7.460 6.230 -16.49% CERS 5.500 4.775 -13.18% GNFT.PA 69.090 60.000 -13.16% SNMX 6.110 5.320 -12.93% EXAS 25.655 22.470 -12.41%